Abstract
Somatic cell hybridization experiments between tumorigenic and nontumorigenic cells indicate that the differentiated state of the cells carrying the activated oncogene is important in the regulation of their expression.
Similar content being viewed by others
References
ar-RushdiA., NishikuraK., EriksonJ., WattR., RoveraG. and CroceC.M. (1983): Differential expression of the translocated and of the untranslocated c-myc gene in Burkitt lymphoma. - Science 222, 390–393.
AvilesD., JamiJ., RoussetJ.P. and RitzE. (1977): Tumor x host cell hybrids in the mouse: chromosomes from the normal cell parent maintained in malignant hybrid tumors. - J. National Cancer Institute 58, 1391–1399.
BregulaV., KleinG. and HarrisH. (1971): The analysis of malignancy by cell fusion. III Hybrids between diploid fibroblasts and other tumour cells. - J. Cell Science 8, 681–692.
ColbyW., CheneE., SmithD. and LevinsonA. (1983): Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29. - Nature 301, 722–725.
CroceC.M., GirardiA.J. and KoprowskiH. (1973): Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7. - Proc. Natl. Acad. Sci. USA 70, 3617–3620.
CroceC.M. and KoprowskiH. (1974): Concordant segregation of the expression of SV40 T-antigen and human chromosome 7 in mouse human hybrid subclones. - J. Exp. Med. 139, 1350–1353.
CroceC.M. and KoprowskiH. (1974): Somatic cell hybrids between peritoneal mouse macrophages and SV40-transformed human cells. I. Positive control of the transformed phenotype by the human chromosome 7 carrying the SV40 genome.- J. Exp. Med. 140, 1221–1229.
CroceC.M. and KoprowskiH. (1975): Assignment of gene(s) for cell transformation to human chromosome 7 carrying the SV40 genome. - Proc. Natl. Acad. Sci. USA 72, 1658–1660.
CroceC.M., AdenD. and KoprowskiH. (1975): Somatic cell hybrids between mouse peritoneal macrophages and SV40 transformed human cell. II: Presence of the human chromosome 7 carrying the SV40 genome in the cells of tumors induced by the hybrid cells. - Proc. Natl. Acad. Sci. USA 72, 1397–1400.
CroceC.M., AdenD. and KoprowskiH. (1975): Tumorigenicity of mouse-human diploid hybrids in nude mice. - Science 190, 1200–1202.
CroceC.M. (1977): Assignment of the integration site for Simian virus 40 to chromosome 17 in GM54VA, a human cell line transformed by Simian virus 40. - Proc. Natl. Acad. Sci. USA 74, 315–318.
CroceC.M., ShanderM., MartinisJ., CicurelL., D'AnconaG.G., DolbyT.W. and KoprowskiH. (1979): Chromosomal location of the human immunoglobulin heavy chain genes. - Proc. Natl. Acad. Sci. USA 76, 3416–3419.
CroceC.M., ThierfelderW., EriksonJ., NishikuraK., FinanJ., LenoirG. and NowellP.C. (1983): Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C locus in Burkitt lymphoma. - Proc. Natl. Acad. Sci. USA 80, 6922–6926.
CroceC.M., EriksonJ., ar-RushdiA., AdenD., NishikuraK. (1984): The translocated c-myc oncogene of Burkitt lymphoma is transcribed in plasma cells and repressed in lymphoblastoid cells. - Proc. Natl. Acad. Sci. USA 81, 3170–3174.
Dalla FaveraR., BregniM., EriksonJ., PattersonD., GalloR.C. and CroceC.M. (1982): Human c-myc onc-gene is located in the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824–7827.
DefendiV., EphrussiB., KoprowskiH. and ToshihidaM.C. (1967): Properties of hybrids between polyoma-transformed and normal mouse cells. -Proc. Natl. Acad. Sci. USA 57, 299–305.
EmanuelB.S., SeldenJ.R., ChagantiR.S.K., JhanwarS., NowellP.C. and CroceC.M. (1984): The 2p breakpoint of a 2;8 translocation in Burkitt lymphoma interrupts the V locus. - Proc. Natl. Acad. Sci. USA 81, 2444–2446.
EriksonJ., MartinisJ. and CroceC.M. (1981): Assignment of the human genes for immunoglobulin chains to chromosome 22. - Nature 294, 173–175.
EriksonJ., NishikuraK., ar-RushdiA., FinanJ., EmanuelB., LenoirG., NowellP.C. and CroceC.M. (1983): Translocation of an immunoglobulin locus to a region 3′ of an unrearranged c-myc oncogene enhances c-myc transcription. - Proc. Natl. Acad. Sci. USA 80, 7581–7585.
EriksonJ., ar-RushdiA., DrwingaH.L., NowellP.C. and CroceC.M. (1983): Transcriptional activation of the c-myc oncogene in Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 80, 820–324.
HarrisH., MillerO.J., KleinG., WorstP. and TachibanaT. (1969): Suppression of malignancy by cell fusion. - Nature 223, 363–368.
HaywardW.S., NeelB.G., AstrinS.M. (1981): Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. - Nature 290, 475–480.
JonassonJ., PoveyS. and HarrisH. (1977): The analysis of malignancy by cell fusion — VII. Cytogenetic analysis of hybrids between malignant and diploid cells of tumors derived from them.- J. Cell Science 24, 217–254.
KleinG. (1981): The role of gene dosage and genetic transposition in carcinogenesis. - Nature 294, 313–318.
KoprowskiH. and CroceC.M. (1977): Tumorigenicity of simian virus 40 transformed human cells and mouse-human hybrids in nude mice. -Proc. Natl. Acad. Sci. USA 74, 1141–1146.
LenoirG.M., Preud'HommeJ.L., BernheimA. and BergerR. (1982): Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma. - Nature 298, 474–476.
ManolovG. and ManolovaY. (1971): Marker band in one chromosome 14 from Burkitt lymphoma. Nature 237, 33–34.
NishikuraK., ar-RushdiA., AriksonJ., WattR., RoveraG. and CroceC.M. (1983): Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. - Proc. Natl. Acad. Sci. USA 80, 4822–4826.
NishikuraK., ar-RhsudiA., EriksonJ., DeJesusE., DuganD. and CroceC.M. (1984): Repression of rearranged μ gene and translocated c-myc in mouse 3T3 cells × Burkitt lymphoma cell hybrids. - Science 224, 399–402.
NowellP.C. and HungerfordD.A. (1960): A minute chromosome in chronic granulocytic leukemia. - Science 132, 1497.
RowleyJ.D. (1973): A new consistent chromosomal abnormality in chronic myclogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. - Nature 243, 290–293.
RowleyJ.D. (1983): Identification of the constant chromosome regions involved in human, hematologic malignant disease. - Science 216, 749–751.
ScarlettaL.J. and EphrussiB. (1965): Hybridization of normal. and neoplastic cells in vitro. - Nature 205, 1169–171.
StanbridgeE.J. and WilkinsonA. (1978): Analysis of malignancy in human cells: malignant and transformed phenotypes are under separate genetic control. - Proc. Natl. Acad. Sci. USA 75, 1466–1469.
WattR., StantonL.W., MarcuK.B., GalloR.C., CroceC.M. and RoveraG. (1983): Nucleotide sequence of cloned cDNA of the human c-myc gene. -Nature 303, 725–728.
WattR., NishikuraK., SorrentinoJ., ar-RushdiA., CroceC.M. and RoveraG. (1983): The structure and nucleotide sequence of the 5′ end of the human c-myc gene. - Proc. Natl. Acad. Sci. USA 80, 6307–6311.
WienerF., KleinG. and HarrisH. (1974): The analysis of malignancy by cell fusion. III Hybrids between diploid fibroblasts and other tumour cells. - J. Cell Science 16, 189–198.
YunisJ. (1983): The chromosomal basis of human neoplasia. - Science 221, 227–240.
ZechL., HaglundV., NilssonN., KleinG. (1976): Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. - International Journal of Cancer 17, 47–56.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Croce, C.M. Genetics of B-cell neoplasia. Eur J Epidemiol 1, 11–18 (1985). https://doi.org/10.1007/BF00162307
Issue Date:
DOI: https://doi.org/10.1007/BF00162307